Throughout this century, the characterization of phenotypic variants of the mouse has played an invaluable role in the establishment of mammalian genetics and in furthering our understanding of embryology and the cellular mechanisms underlying mammalian development. Until very recently, molecular characterization of these mutants was hampered by the size and complexity of the mouse genome and by the difficulties in translating complex developmental phenotypes into feasible cloning strategies. With recent advances in recombinant DNA technology and improvements in genetic and physical mapping methodologies, the molecular definition of this large collection of mutants is now possible.
Two broad genetic strategies have been taken to understand mammalian development at the molecular level ( Table 1 ). Genes that may play critical roles in murine development have been identified by (1) cloning murine homologs of genes essential for normal development in other organisms (for reviews, see Holland and Hogan 1988; Kessel and Gruss 1990) , (2) identifying genes involved in cellular proliferation and tumorigenesis (for reviews, see Adamson 1987; Mercola and Stiles 1988; Boettiger 1989) , and (3) screening techniques based on differential expression patterns in the embryo (Allen et al. 1988; Kothary et al. 1988; Gossler et al. 1989 ). The roles played by such genes in mammals have been largely inferred from the biochemical properties of their protein products, their expression patterns in the developing embryo, and by extrapolation from the available genetic evidence of their homologs in other experimental systems, particularly Drosophila melanogaster. Direct genetic analysis of the function of such genes in mammalian development is now possible by generating gain or loss of function of mutations through the random or targeted insertion of exogenous DNA into the mouse germ line (for reviews, see Jaenisch 1988; Capecchi 1989; Rossant and Joyner 1989; Westphal and Gruss 1989) .
A second and complementary approach is provided by the molecular analysis of existing mouse mutants (Table  1) . Many of the 1300 or so genetic loci currently mapped in the mouse were identified originally on the basis of a mutant developmental phenotype (Lyon and Searle 1989). This collection of "classic" mutants has been recently augmented by the use of highly efficient chemical mutagens (for review, see Rinchik 1991) and by the production of insertional mutations by transgenic techniques. The rapid increase in the number of cloned genes, coupled with improved genetic and physical mapping techniques (Taylor 1978; Avner et al. 1988; Schlessinger 1990; Copeland and Jenkins 1991) , has made the molecular definition of such mutant mouse strains an attainable goal. In this review we consider some recent examples that serve to illustrate how molecular analyses of existing mouse mutant stocks are providing insights into the developmental functions of a variety of growth factors, receptors, and putative or known transcription factors. This work is also revealing the domains and residues critical for in vivo functions of these protein families, providing models for the types of mutations that may be usefully employed in the generation of gain-or loss-offunction mutations in the mouse germ line. In addition, novel protein families essential for normal development are being identified on the basis of the phenotypic consequences of their mutation.
Direct association of cloned genes with mutant loci
The rapid increase in cloning and mapping of genes in both man and mouse is resulting in increasingly detailed genetic and physical linkage maps, providing cloned markers close to specific mutant loci. In some cases, a connection can be made between the phenotypic properties of the mutant locus and the known biochemical properties and/or expression pattem of a closely linked gene, providing a basis for further investigation of the relationship between the mutant locus and a candidate gene. A relatively large number of mutant loci have been successfully identified in this way (Table 2) . (Krulewski et al. 1989) , extra toes (Xt) (Pohl et al. 1990) , hotfoot (ho) (Gordon et al. 1990) , pygmy {pg) (Xiang et al. 1990) , and microophthalmia {mi) (l. Krakowsky and J. Lingrel, pers. comm.; H. Amheiter, Y. Hara, L. Forrester, and A. Bemstein, unpubl.) . Others, such as MyKI03 (Wilkie and Palmiter 1987) , symplastic spermatids (sys) {MacGregor et al. 1990), and Hf358 (Radice et al. 1991) represent novel developmental loci. An additional S1 allele has also been generated by transgene insertional mutagenesis (Keller et al. 1990 ).
Mutations at the Dominant-white spotting (W) locus (Little 1915 ) on chromosome 5, or the Steel (Sl) locus (Sarvella and Russell 1956 ) on chromosome 10, result in similar phenotypes that can include severe macrocytic anemia, sterility, and coat color abnormalities. Transplantation, tissue chimera, and in vitro cocuhure assays have established that the cellular bases of W and S1 mutations are distinct: W mutations act intrinsically within stem cells of hematopoietic and melanogenic lineages, whereas the SI defect acts within the microenvironment of such cells (Russell 1979; Silvers 1979) .
Insight into the molecular basis of the W and S1 mutations was obtained with the finding that the receptor tyrosine kinase c-kit mapped to human chromosome 4 (Yarden et al. 1987 ) in a region syntenic with mouse chromosome 5, where the W locus is located. Together with the known biology of W mutants, this made c-kit a highly attractive candidate gene for the W locus. This possibility was confirmed by showing extremely tight genetic linkage between W and c-kit in interspecific crosses (Chabot et al. 1988; Geissler et al. 1988) , and mutations affecting c-kit structure, expression, and/or function in all 11 independent W alleles analyzed to date (Chabot et al. 1988; Geissler et al. 1988; Dubreuil et al. 1990; Nocka et al. 1990a; Reith et al. 1990; Tan et al. 1990) .
The identification of c-kit as the product of the W locus strongly suggested that the S1 locus may encode a ligand for the c-kit receptor (Chabot et al. 1988 ). Subsequently, a Kit ligand was identified (Flanagan and Leder 1990; Nocka et al. 1990b; Williams et al. 1990; Zsebo et al. 1990a ). Cloning of this growth factor and subsequent analyses established that it does indeed map to the S1 locus and is rearranged or deleted in independent SI alleles lAnderson et Copeland et al. 1990; Huang et al. 1990; Martin et al. 1990; Zsebo et al. 1990b) . Taken together, W and $1 mutant animals provide elegant genetic evidence for the roles played by Kit-mediated signal transduction pathways in the development of hematopoietic, melanogenic, and germ cell lineages. Questions regarding the function of the Kit signaling pathway remain, particularly in neural tissues where no phenotype is yet apparent in W or S1 mutants despite expression of both receptor and ligand in these tissues (Matsui et al. 1990; E. Keshet et al., pers. comm.; B. Motro et al., in prep.) .
Another example of the roles of growth factor-mediated signaling pathways in development is provided by the osteopetrotic (op) mutant mouse, in which skeletal defects result from a restricted capacity for bone remodeling due to an osteoclast deficiency (Marks and Lane 1976) . A reduction in macrophage numbers has also been noted in this mutant, a consequence of a defective microenvironment rather than an intrinsic stem cell defect (Wiktor-Jedrzejczak et al. 1982; Marks 1984) . The mapping of the macrophage growth factor CSF-1 close to op on chromosome 3 (Buchberg et al. 1989; Gisselbrecht et al. 1989 ) provided a suitable candidate gene for this mutant locus. Together with the absence of biologically active CSF-1 in op/op cells (Wiktor-Jedrzejczak et al. 1990; Yoshida et al. 1990 ) and the identification of a frameshift mutation in the CSF-l-coding region in op mice {Yoshida et al. 1990) , it is likely that the op phenotype results from a loss-of-function mutation in the CSF-1 gene.
Although the phenotype of op/CSF-1 mutant animals is consistent with the known properties of CSF-1 for in vitro maturation of macrophages and osteoclasts, newborn op homozygotes appear normal and no placental defect is apparent despite high levels of CSF-1 and its receptor c-fms during placental development (Bartocci et al. 1986; Pollard et al. 1987; Arceci et al. 1989; Regenstrief and Rossant 1989) . A maternal supply of CSF-1, and increased levels of other cytokines in op/op cells and tissues (Wiktor-Jedrzejczak et al. 1990) , may compensate to some extent for the absence of embryonic CSF-1, thus minimizing the phenotypic consequences of the CSF-1 deficiency in op/op mice.
The candidate gene approach has also provided direct genetic evidence for the function of known or putative transcription factors in mammalian development. Mutations at the undulated (un) locus (chromosome 2) (Wright 1947) confer vertebral abnormalities over the entire length of the vertebral colunm, a consequence of perturbation in the position of the boundary between anterior and posterior sclerotome halves in the mid-gestation embryo (Gruneberg 1950 (Gruneberg , 1954 ). An understanding of the molecular basis of this mutant has been made possible by the mapping of the Pax-1 gene to the un locus (Balling et al. 1988) .
Pax-1 was isolated as a potential murine developmental control gene on the basis of its homology to the Drosophila paired-box, originally identified in a subset of segmentation genes known to play clitical roles during Drosophila development (Bopp et al. 1986; Akam et al. 1987) . The definition of mutations in Pax-1 gene structure or expression in three independent un alleles (Bailing et al. 1988; Kessel and Gruss 1990) , and the restriction of Pax-1 expression to posterior sclerotome halves during normal vertebra development (Deutsch et al. 1988) , strongly implicate mutations in Pax-1 as playing a causal role in the generation of the un phenotype. Moreover, the phenotypic consequences of mutation of Pax-1 suggest that this putative transcription factor may play a directive role in sclerotome determination.
Like coat color or skeletal mutants, genetic dwarfism is one of the more easily assayed mutant phenotypes in mouse breeding stocks and a number of spontaneous dwarf mutant loci have been identified over the years. Two such mutants are Snell's dwarf (dw) on chromosome 16 (Snell 1929 )and Ame's dwarf {df) on chromosome 11 (Bartke 1964) . Mice homozygous for either of these mutations have severely hypoplastic anterior pituitaries and are depleted in somatotroph, lactotroph, and thyrotroph cell types resulting from primary defects intrinsic to the pituitary (Carsner and Rennels 1960) . The mapping of the POU domain-containing transcription factor pit-1 to chromosome 16 (Camper et al. 1990; ) provided a suitable candidate gene for the dw lOCUS.
pit-1 was identified as a transcription factor that can
trans-activate prolactin and growth hormone gene promoters and is restricted to the nuclei of somatotroph, lactotroph, and thyrotroph pituitary cell types (Bodner et al. 1988; Ingraham et al. 1988; Crenshaw et al. 1989; Mangalam et al. 1989; Simmons et al. 1990 ). The detection of genomic rearrangement of the pit-1 locus in the dw a allele, and point substitution of a highly conserved tryptophan residue within the POU domain of pit-1 in the original dw allele ), provides direct evidence that the dw phenotype is a consequence of lossof-function mutations in the pit-1 transcription factor. Moreover, this analysis suggests that pit-1 is essential for the survival and/or proliferation of both lactotroph and somatotroph lineages, in addition to its putative role in mediating hormone expression in these cell types and, furthermore, indicates that pit-1 may also play a functional role in cells of the thyrotroph lineage.
Physical mapping approaches
An alternative to direct association of a candidate gene with a mutant phenotype is provided by the direct physical mapping and cloning of a mutant locus. The initiation of such an approach requires the availability of cloned markers that map close to the locus of interest. These can be provided in two ways.
Insertional mutagenesis
A number of mouse mutant phenotypes result from disruption of a functional transcription unit by either spontaneous or experimentally induced insertion of DNA elements into a functional locus. It is possible to use the insertional mutagenic element as a "cloning tag" to gain direct access to a mutant locus of interest (Table 2) . Tags may take the form of spontaneous insertion of endogenous retroviral elements, as in the case of the dilute (d) (Jenkins et al. 1981; Copeland et al. 1983; Mercer et al. 1991) , hairless (Stoye et al. 1988) , and pink-eyed unstable (Brilliant et al. 1991) loci, or experimental introduction of ecotropic proviruses, as used to generate the Mov series of mutant mouse strains (Jaenisch 1976) . In addition to these retrovirus insertional events, DNA microinjection into fertilized eggs has provided additional insertional mutagenic events at a frequency estimated to be as high as 5-10% (Jaenisch 1988) . Although such tags can greatly facilitate the molecular definition of particular mutant loci, genomic rearrangements at the site of transgene integration (Covarrubias et al. 1986 (Covarrubias et al. , 1987 Mahon et al. 1988 ) may complicate molecular analysis. Nevertheless, transgene insertions provide a powerful method of cloning developmentally important loci, as exemplified by the identification of the products of the mouse limb deformity (Id) locus (Cupp 1960) .
Id/Id animals are characterized by fusions and reduction in the distal bones of the limbs that can be traced to a defect in limb bud development (Lyon and Searle 1989; Zeller et al. 1989 ). The molecular definition of the ld locus involved physical mapping and cloning approaches made possible by the fortuitous generation of novel ld alleles by insertional mutagenesis in a transgenic experiment (Woychik et al. 1985) . Using the transgene as a "cloning tag," evolutionarily conserved coding sequences of the ld locus were cloned and found to encode a variety of novel proline-rich proteins, termed formins, produced from a family of differentially spliced, lowabundance mRNA species expressed in a wide variety of cell types (Zeller et al. 1989; Woychik et al. 1990 ). In two independent ld alleles, a common subset of formin mRNA species are not synthesized , indicating that functional disruption of the formin locus is causal in the generation of at least some ld alleles. The availability of the formin reagents, along with ld mutant mice, will make it possible to analyze the functions of this complex family of proteins in limb morphogenesis.
Walking to a mutant locus
In the absence of an insertional cloning tag, the molecular definition of a mutant locus can be achieved only by direct physical mapping, cloning, and chromosome walking procedures. Such analysis is initiated by the use of the cloned markers nearest to the mutant locus; but despite the rapid increase in the number of cloned and mapped probes, markers may be a considerable distance from the locus of interest. A further limitation is imposed by the requirement for a large number of welldefined deletion and/or translocation mutant alleles to facilitate the construction of detailed physical maps of the mutant locus. Nevertheless, this approach has been successful in the identification of certain genes involved in human disease and embryological development (Lee et al. 1987; Riordan et al. 1989; Rommens et al. 1989; Bonetta et al. 1990; Call et al. 1990; Cawthon et al. 1990; Gessler et al. 1990; Sinclair et al. 1990; Viskochil et al. 1990 ). This strategy is also leading to the molecular cloning of murine developmental loci.
Mutations at the Brachyury (T) locus (chromosome 17) (Dobrovolskaia-Zavadskaia 1927) induce mild dominant defects in vertebrae development. T/T homozygotes die at -10 days of gestation, a consequence of a primary failure to produce sufficient mesoderm during primitive streak formation at -7.5-8.5 days of gestation (Chesley 1935; Yanagisawa et al. 1981) . A large number of T alleles bearing a variety of deletions and chromosomal breakpoints have been isolated in the past 50 years and have provided the basis for physical mapping of the T locus to a 75-kb region of DNA . Within this region a single gene was identified, and conserved genomic fragments were used to isolate a cDNA clone of novel nucleotide sequence, pme75. Deletion of pme75-encoded sequences in many T alleles and genomic rearrangement of pme75 in at least one T allele , coupled with the restricted expression of pme75 in target cell types of T mutants (Wilkinson et al. 1990 ), strongly suggests that this eDNA clone represents a product of the T locus and implicates this gene as playing a key role in mesoderm formation. The availability of the T protein and T mutant mice will fa-cilitate studies on the interactions between T and other proteins involved in mesoderm formation (Rosa 1989; Mitrani et al. 1990; Smith et al. 1990; Thomsen et al. 1990) , providing important insights into the molecular mechanisms involved in vertebrate mesoderm formation.
An elegant example of how human and mouse genetic analyses can be used in parallel to identify developmentally important genes is provided by the identification of the mammalian sex-determination gene. In man, analySiS of sex-reversed individuals facilitated the construction of detailed genetic and physical maps restricting the testis-determining gene (TDF in human; Tdy in mouse) to a 60-kb fragment of the Y chromosome. Within this region, a highly conserved Y-specific gene, SRY, was identified ). Further evidence supporting the notion that SRY is the mammalian sex-determining gene has come from the identification of point substitutions in SRY in some XY females that lack cytogenetic mutations in Y Jager et al. 1990 ).
In the mouse, a number of mutations have been identified that result in sex-reversed phenotypes. The Sxr mutation (Cattanach et al. 1971 ) results in X/X or X/O individuals developing as males, a consequence of translocation of a small region of the Y chromosome to the distal end of Y that undergoes recombination with X during meiosis. A derivative mutant, Sxr' (McClaren et al. 1984) , is deleted for some genes translocated in Sxr but still gives rise to sex-reversed mice and so represents the smallest region of mouse Y that contains Tdy. Another sex-reversed mutant, Tdy m~ (L0vell-Badge and Robertson 1990), produces XY females and can be complemented by Sxr', suggesting that this represents a lossof-function mutation in Tdy. Consistent with the phen0types of mouse sex-reversed mutants, the mouse h0-molog of SRY (Sty) was found to be present in the translocated region in Sxr and Sxr' mutants but is deleted in Tdy ~z mutants (Gubbay et al. 1990) . Moreover, Sry is a member of a family of at least five closely related mouse genes, all of which contain sequences homologous to DNA-binding domains (Gubbay et al. 1990 ).
Future prospects
Developmental mutants in the mouse have played a key role in the establishment of mouse genetics and in the elucidation of developmental strategies in mammals. However, only within the last several years has it been possible to address the molecular bases of these mutant phenotypes. This analysis has already brought together proteins with well-defined biochemical properties and mutant strains that have been analyzed by genetic, cellular, and embryological approaches over many years. In addition, this genetic approach has led to the discovery of novel proteins that play key roles in development.
To date, only a very small proportion of the available mouse mutations have been accessed at the molecular level. As exemplified by W and $1 mutants, identification of the molecular defect in one mutant locus can facilitate the definition of other loci and also provide a basis for the generation of loss-of-function mutations in related proteins (A.D. Reith et al., in prep .) The continued cloning and mapping of novel genes and anonymous probes will provide ever more detailed genetic and physical maps of both human and mouse genomes. Coupled with the utilization of cloning vectors, such as yeast artificial chromosomes (gchlessinger 1990} and phage Pl vectors (Sternberg et al. 1990} , the cloning of candidate genes for a given mutation by walking procedures should become a less formidable task than it is at present. Moreover, the development of techniques to introduce large DNA fragments into the mouse germ line (Richa and Lo 1989; Pavan et al. 1990 ) promises to provide a basis for genetic complementation assays to functionally define mutant loci, facilitating an entirely new strategy for cloning developmental genes in mammals. Over the next several years, this fusion of complementary genetic, biological, and biochemical approaches will undoubtedly lead to the molecular definition of many pre-existing mouse mutations. These approaches, coupled with genetargeting strategies to generate novel developmental mutants, will lead to a fuller understanding of the molecular mechanisms that regulate normal mammalian development. C0sman, and D.E. Williams. 1990 . Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63: 235--243. Arceci, R.J., F. Shanahan, E.R. Stanley, and J.W. Pollard. 1989. Temporal expression and location of colony-stimulating factor 1 (CSF-11 and its receptor in the female reproductive tract are consistent with CSF-l-regulated placental development. Proc. Natl. Avner, P., L. Amar, L. Dandalo, and J.L. Guenet. 1988 . Genetic analysis of the mouse using interspecific crosses. Trends . Balling, R., U. Deutsch, and P. Gruss. 1988 . undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax-1. Cell 55: 531-535.
GENES & DEVELOPMENT 1119
Cold Spring Harbor Laboratory Press on August 14, 2017 -Published by genesdev.cshlp.org Downloaded from
